These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 20087343)
1. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. Mahalingam D; Natoni A; Keane M; Samali A; Szegezdi E Br J Cancer; 2010 Feb; 102(4):754-64. PubMed ID: 20087343 [TBL] [Abstract][Full Text] [Related]
2. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL. Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S Cell Oncol (Dordr); 2011 Jun; 34(3):245-59. PubMed ID: 21538027 [TBL] [Abstract][Full Text] [Related]
4. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde. Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580 [TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N; Poulaki V; Mitsiades C; Tsokos M Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151 [TBL] [Abstract][Full Text] [Related]
6. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis. Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484 [TBL] [Abstract][Full Text] [Related]
7. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
8. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation. Fan S; Li Y; Yue P; Khuri FR; Sun SY Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945 [TBL] [Abstract][Full Text] [Related]
9. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis. Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956 [TBL] [Abstract][Full Text] [Related]
10. Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5. van Geelen CM; Pennarun B; Le PT; de Vries EG; de Jong S BMC Cancer; 2011 Jan; 11():39. PubMed ID: 21272366 [TBL] [Abstract][Full Text] [Related]
11. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours. Jalving M; Heijink DM; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; Sluiter WJ; de Vries EG; Kleibeuker JH; de Jong S Carcinogenesis; 2014 May; 35(5):1092-9. PubMed ID: 24379239 [TBL] [Abstract][Full Text] [Related]
12. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions. Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392 [TBL] [Abstract][Full Text] [Related]
13. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. Kuang AA; Diehl GE; Zhang J; Winoto A J Biol Chem; 2000 Aug; 275(33):25065-8. PubMed ID: 10862756 [TBL] [Abstract][Full Text] [Related]
14. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells. Zou W; Liu X; Yue P; Khuri FR; Sun SY Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826 [TBL] [Abstract][Full Text] [Related]
15. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5. Lemke J; Noack A; Adam D; Tchikov V; Bertsch U; Röder C; Schütze S; Wajant H; Kalthoff H; Trauzold A J Mol Med (Berl); 2010 Jul; 88(7):729-40. PubMed ID: 20354842 [TBL] [Abstract][Full Text] [Related]
16. Death receptor 5 is activated by fucosylation in colon cancer cells. Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines. Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726 [TBL] [Abstract][Full Text] [Related]
18. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells. Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T Cancer Lett; 2010 Jan; 287(1):98-108. PubMed ID: 19577358 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL. Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530 [TBL] [Abstract][Full Text] [Related]
20. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer. Yang J; Li G; Zhang K Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]